ACS* | Men glucose <200 | Women glucose <200 | Men glucose ≥200 | Women glucose ≥200 | p †† |
---|---|---|---|---|---|
Patients | 454 (47.3) | 242 (25.2) | 142 (14.8) | 121 (12.6) | |
Age (years) † | 60.1 ± 11.4 | 61.9 ± 11.7 | 63.1 ± 11.3 | 64.6 ± 12.9 | <0.001 |
Prior coronary artery disease, n (%) | 244 (53.7) | 113 (46.7) | 81 (57.0) | 69 (57.0) | 0,129 |
Hypertension, n (%) | 338 (74.4) | 197 (81.4) | 122 (85.9) | 112 (92.6) | <0.001 |
Current smoker, n (%) | 119 (26.2) | 53 (21.9) | 23 (16.2) | 17 (14.0) | 0,008 |
Dyslipidemia, n (%) | 192 (42.3) | 133 (55.0) | 73 (51.4) | 68 (56.2) | 0,002 |
Diabetes mellitus, n (%) | 80 (17.6) | 50 (20.7) | 103 (72.5) | 93 (76.9) | <0.001 |
Family history of coronary artery disease, n (%) | 77 (17.0) | 40 (16.5) | 23 (16.2) | 23 (19.0) | 0,929 |
Hemoglobin (g/dL) | 14.3 ± 1.8 | 13.2 ± 1.5 | 13.8 ± 1.9 | 12.9 ± 1.8 | <0.001 |
Serum creatinine (mg/dL) | 1.2 ± 0.8 | 1.1 ± 1.3 | 1.3 ± 1.0 | 1.3 ± 1.4 | 0,331 |
Troponin I (ng/mL) | 25.4 ± 44.4 | 14.8 ± 32.9 | 25.0 ± 44.7 | 16.6 ± 31.8 | 0,003 |
Cholesterol (mg/dL) | 175.6 ± 44.6 | 194.5 ± 54.3 | 166.5 ± 43.9 | 188.6 ± 43.1 | <0.001 |
Admission glucose (mg/dL) | 101.6 ± 15.8 | 100.0 ± 14.9 | 211.2 ± 67.7 | 229.0 ± 84.1 | <0.001 |
Ejection fraction (%) | 50.9 ± 14.2 | 58.2 ± 13.3 | 46.8 ± 14.9 | 51.9 ± 15.6 | <0.001 |
Angiography, n (%) | 445 (98.0) | 229 (94.6) | 133 (93.7) | 115 (95.0) | 0,036 |
Medical therapy only, n (%) | 134 (29.5) | 88 (36.4) | 42 (29.6) | 44 (36.4) | 0,184 |
Percutaneous coronary intervention, n (%) | 298 (65.6) | 137 (56.6) | 84 (59.2) | 66 (54.6) | 0,038 |
Surgery, n (%) | 23 (5.1) | 19 (7.8) | 16 (11.3) | 12 (9.9) | 0,046 |
Length of stay (days) | 5.0 ± 6.6 | 5.7 ± 10.5 | 8.2 ± 16.1 | 7.2 ± 9.6 | 0,003 |
Mortality, n (%) | 6 (1.3) | 4 (1.6) | 15 (10.6) | 10 (8.3) | <0.001 |
UA | |||||
Patients, n (%) | 132 (43.4) | 100 (32.9) | 32 (10.5) | 40 (13.2) | |
Age (years)* | 59.9 ± 10.9 | 60.7 ± 9.6 | 61.6 ± 10.7 | 62.5 ± 10.8 | 0.537 |
Prior coronary artery disease, n (%) | 91 (68.9) | 55 (55.0) | 27 (84.4) | 25 (62.5) | 0.013 |
Hypertension, n (%) | 103 (78.0) | 88 (88.0) | 31 (96.9) | 36 (90.0) | 0.019 |
Current smoker, n (%) | 25 (18.9) | 16 (16.0) | 6 (18.7) | 4 (10.0) | 0.595 |
Dyslipidemia, n (%) | 68 (51.5) | 65 (65.0) | 17 (53.1) | 21 (52.5) | 0.197 |
Diabetes mellitus, n (%) | 27 (20.5) | 23 (23.0) | 24 (75.0) | 30 (75.0) | <0.001 |
Family history of coronary artery disease, n (%) | 22 (16.7) | 14 (14.0) | 4 (12.5) | 4 (10.0) | 0.734 |
Hemoglobin (g/dL) | 14.1 ± 1.7 | 13.3 ± 1.4 | 13.9 ± 1.9 | 13.5 ± 1.5 | 0.002 |
Serum creatinine (mg/dL) | 1.3 ± 1.2 | 0.9 ± 0.3 | 1.2 ± 0.5 | 1.3 ± 1.5 | 0.032 |
Troponin I (ng/mL) | 1.0 ± 3.7 | 0.5 ± 1.6 | 1.2 ± 3.5 | 3.7 ± 16.0 | 0.067 |
Cholesterol (mg/dL) | 176.3 ± 44.1 | 193.9 ± 46.7 | 178.6 ± 63.5 | 200.5 ± 48.9 | 0.017 |
Admission glucose (mg/dL) | 99.6 (14.6) | 99.3 (15.4) | 222.5 (66.3) | 209.5 (67.3) | <0.001 |
Ejection fraction (%)† | 56.1 ± 13.7 | 59.5 ± 12.8 | 50.7 ± 15.5 | 55.5 ± 15.2 | 0.069 |
Angiography, n (%) | 127 (96.2) | 93 (93.0) | 30 (93.8) | 39 (97.5) | 0.593 |
Medical therapy only, n (%) | 57 (43.2) | 53 (53.0) | 11 (34.4) | 17 (42.5) | 0.231 |
Percutaneous coronary intervention, n (%) | 67 (50.8) | 40 (40.0) | 17 (53.1) | 21 (52.5) | 0.306 |
Surgery, n (%) | 8 (6.1) | 7 (7.0) | 4 (12.5) | 2 (5.0) | 0.587 |
Length of stay (days) | 4.9 ± 9.1 | 3.5 ± 3.2 | 7.3 ± 14.6 | 4.2 ± 4.9 | 0.115 |
Mortality, n (%) | 1 (0.8) | 0 | 4 (12.5) | 0 | <0.001 |
NSTEMI | |||||
Patients, n (%) | 208 (46.9) | 103 (23.3) | 72 (16.3) | 60 (13.5) | |
Age (years)* | 61.2 ± 11.4 | 64.4 ± 12.9 | 65.7 ± 10.3 | 65.7 ± 12.5 | 0.006 |
Prior coronary artery disease, n (%) | 115 (55.3) | 46 (44.7) | 42 (58.3) | 36 (60.0) | 0.159 |
Hypertension, n (%) | 161 (77.4) | 85 (82.5) | 64 (88.9) | 55 (91.7) | 0.026 |
Current smoker, n (%) | 50 (24.0) | 21 (20.4) | 7 (9.7) | 11 (18.3) | 0.073 |
Dyslipidemia, n (%) | 97 (46.6) | 53 (51.5) | 41 (56.9) | 37 (61.70 | 0.151 |
Diabetes mellitus, n (%) | 41 (19.7) | 23 (22.3) | 55 (76.4) | 48 (80.0) | <0.001 |
Family history of coronary artery disease, n (%) | 37 (17.8) | 19 (18.4) | 14 (19.4) | 14 (23.3) | 0.811 |
Hemoglobin (g/dL) | 14.3 ± 1.8 | 13.0 ± 1.6 | 13.2 ± 2.0 | 12.7 ± 1.9 | <0.001 |
Serum creatinine (mg/dL) | 1.2 ± 0.7 | 1.3 ± 1.9 | 1.5 ± 1.4 | 1.4 ± 1.5 | 0.586 |
Troponin I (ng/mL) | 22.6 ± 36.9 | 18.4 ± 34.4 | 19.5 ± 31.2 | 18.9 ± 29.7 | 0.734 |
Cholesterol (mg/dL) | 178.4 ± 47.2 | 194.5 ± 61.2 | 167.1 ± 38.0 | 182.6 ± 39.8 | 0.011 |
Admission glucose (mg/dL) | 100.8 ± 16.5 | 101.9 ± 14.8 | 202.7 ± 62.6 | 241.3 ± 98.7 | <0.001 |
Ejection fraction (%)† | 49.8 ± 14.9 | 59.3 ± 13.5 | 44.7 ± 14.9 | 49.0 ± 16.0 | <0.001 |
Angiography, n (%) | 204 (98.1) | 97 (94.2) | 65 (90.3) | 55 (91.7) | 0.028 |
Medical therapy only, n (%) | 63 (30.3) | 31 (30.1) | 27 (37.5) | 26 (43.3) | 0.202 |
Percutaneous coronary intervention, n (%) | 135 (64.9) | 66 (64.1) | 36 (50.0) | 26 (43.3) | 0.006 |
Surgery, n (%) | 10 (4.8) | 8 (7.8) | 9 (12.5) | 8 (13.3) | 0.064 |
Length of stay (days) | 5.1 ± 5.2 | 7.7 ± 14.5 | 10.7 ± 20.1 | 9.9 ± 12.4 | 0.002 |
Mortality, n (%) | 4 (1.9) | 3 (2.9) | 8 (11.1) | 7 (11.7) | <0.001 |
STEMI | |||||
Patients, n (%) | 114 (53.8) | 39 (18.4) | 38 (17.9) | 21 (9.9) | |
Age (years)* | 58.1 ± 11.9 | 58.7 ± 12.3 | 59.3 ± 12.5 | 65.7 ± 17.1 | 0.096 |
Prior coronary artery disease, n (%) | 38 (33.3) | 12 (30.8) | 12 (31.6) | 8 (38.1) | 0.945 |
Hypertension, n (%) | 74 (64.9) | 24 (61.5) | 27 (71.1) | 21 (100) | 0.009 |
Current smoker, n (%) | 44 (38.6) | 16 (41.0) | 10 (26.3) | 2 (9.5) | 0.036 |
Dyslipidemia, n (%) | 27 (23.7) | 15 (38.5) | 15 (39.5) | 10 (47.6) | 0.052 |
Diabetes mellitus, n (%) | 12 (10.5) | 4 (10.3) | 24 (63.2) | 15 (71.4) | <0.001 |
Family history of coronary artery disease, n (%) | 18 (15.8) | 7 (17.9) | 5 (13.2) | 5 (23.8) | 0.748 |
Hemoglobin (g/dL) | 14.5 ± 1.8 | 13.2 ± 1.6 | 14.8 ± 1.4 | 12.7 ± 2.1 | <0.001 |
Serum creatinine (mg/dL) | 1.2 ± 0.4 | 1.1 ± 1.0 | 1.1 ± 0.4 | 1.1 ± 0.5 | 0.758 |
Troponin I (ng/mL) | 58.8 ± 59.4 | 41.0 ± 48.7 | 56.1 ± 65.3 | 34.7 ± 47.8 | 0.173 |
Cholesterol (mg/dL) | 169.3 ± 39.4 | 195.9 ± 56.6 | 156.5 ± 34.7 | 180.7 ± 36.1 | 0.001 |
Admission glucose (mg/dL) | 105.4 ± 15.4 | 96.7 ± 13.6 | 217.9 ± 77.2 | 230.9 ± 60.3 | <0.001 |
Ejection fraction (%)† | 47.9 ± 12.0 | 51.5 ± 12.1 | 47.9 ± 14.6 | 55.4 ± 13.8 | 0.098 |
Angiography, n (%) | 114 (100.0) | 39 (100.0) | 38 (100.0) | 21 (100.0) | 1.000 |
Medical therapy only, n (%) | 14 (12.3) | 4 (10.3) | 4 (10.5) | 1 (4.8) | 0.786 |
Percutaneous coronary intervention, n (%) | 96 (84.2) | 31 (79.5) | 31 (81.6) | 19 (90.5) | 0.719 |
Surgery, n (%) | 5 (4.4) | 4 (10.3) | 3 (7.9) | 2 (9.5) | 0.543 |
Length of stay (days) | 4.6 ± 5.3 | 5.9 ± 9.2 | 4.2 ± 3.4 | 4.9 ± 2.8 | 0.546 |
Mortality, n (%) | 1 (0.9) | 1 (2.6) | 3 (7.9) | 3 (14.3) | 0.012 |